EASL has published several reports on liver disease in Europe and is commissioning work on future publications.
Geneva, 27 May 2022: In Europe, the number of deaths from liver cancer has doubled in the past 30 years. Screening for liver cancer with an ultrasound examination every six months is an established method to reduce mortality resulting from liver cancer. EASL guidelines recommend that screening for liver cancer is offered to patients with…
Read More
EASL submitted a written statement at the 72nd Session of the WHO Regional Committee for Europe taking place 12- 14 September 2022 in Tel Aviv, Israel. EASL strongly supports the efforts for the prevention and control of Noncommunicable Diseases in the WHO European Region 2016-2025 and asked WHO Europe to incorporate the NAFLD into their…
Read More
Geneva, 3 May 2022: This joint statement of the European Centre for Disease Prevention and Control (ECDC), World Health Organization (WHO) and EASL provides an overview of public health guidance aimed to ensure that the needs of refugees in relation to viral hepatitis are appropriately met, for all stages along the continuum of care from…
Read More
Brussels, 4 March 2022. On this World Obesity Day, social, health and consumer organisations call on the EU to adopt strong regulation to protect children from the marketing of nutritionally poor food. Obesity is on the rise among European citizens, negatively impacting both people’s quality of life and life expectancy and increasing the incidence of…
Read More
EASL and other health organisations wrote a joint press release with regards to the Parliamentary Report “Strengthening Europe in the fight against cancer” (BECA report). The health community is appalled that Members of European Parliament have listened to the alcohol industry rather than to scientists and public health experts.
Read More
EASL recommends extending the Recommendation to liver cancer for high-risk groups living with chronic liver diseases; these patients are identifiable, have a high risk of liver cancer, and can be offered curative treatment if their liver cancer is diagnosed early. Furthermore, liver cancer detection tools are easily available and affordable.
Read More
Joint letter signed by EASL and 15 organisations, was addressed to all Members of the European Parliament. The scope of this initiative was to safeguard the BECA report (whose 145 amendments were fully approved in December 2021) without further changes during the plenary vote on 16 February.
Read More
On the occasion of World Cancer Day and ahead of the plenary vote on the report developed by the BECA committee expected on 15 February, eleven European health organisations call on MEPs to adopt the report with no weakening of its recommendations on cancer prevention.
Read More
The European Association for the Study of the Liver (EASL) aims to contribute to answering this question by stressing the necessity of extending screening programmes to liver cancer, notably for a well-defined population of people at risk of developing liver cancer.
Read More
We call for the adoption of legislation by the European Union (EU) to improve public health, prevent non-communicable diseases and promote children’s rights, by effectively protecting children from the harmful impact of the widespread, ubiquitous and insidious marketing of nutritionally poor food.
Read More